Jiangxi Serum Pharma Industries Co., Ltd. stands as a beacon of excellence in the Chinese pharmaceutical export sector. With over 10 years of specialized experience, we have bridged the gap between advanced manufacturing capabilities and global medical needs. Our core competency lies in the strategic integration of R&D, manufacturing, and global logistics for biological products, vaccines, and Western medicines.
Operating under the rigorous standards of the Search Quality Rater Guidelines, we prioritize E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) in every molecule we supply. From raw material sourcing to finished dosage forms, our supply chain is designed for maximum transparency and clinical efficacy.
Established Foundation
Global Partners
Quality Suppliers
Annual Export Value
Global healthcare systems are shifting from volume-centric to value-centric models. For generic medicine suppliers, this means providing "Information Gain"—demonstrating how specific formulations (like our Co-Crystallization technology) improve patient adherence and clinical outcomes while reducing total cost of care.
The integration of AI in pharmaceutical manufacturing is no longer a luxury. Our adoption of Bio-Fermentation and Pre-Mix services allows for higher purity levels and more stable shelf lives for critical antibiotics like Amoxicillin and Ceftriaxone.
As the FDA and EMA tighten bio-equivalence standards, Serum Pharma ensures all products meet or exceed BP/USP/EP requirements. Our compliance framework is built on a "Quality by Design" (QbD) approach, ensuring every batch of injectable or oral medication is audit-ready.
The generic medicine market is currently undergoing a massive transformation driven by "Patent Cliffs" and the urgent need for therapeutic equity. According to recent market analysis, the demand for high-quality injectables like Cefazolin Sodium and Gentamicin Sulfate is projected to grow by 7.4% CAGR through 2030, particularly in emerging markets where accessibility is paramount.
Furthermore, the emergence of GLP-1 weight-loss medications (such as Orforglipron) and plant-derived compounds like Squalene indicates a shift toward specialized, high-potency molecules. Serum Pharma is at the forefront of this shift, investing in the technology required to stabilize these complex molecules for global distribution.
We mitigate geopolitical risks by maintaining a diversified supplier base of over 200 high-tier manufacturers. Our logistics network ensures cold-chain integrity for sensitive biological products and vaccines.
Procurement success depends on paperwork. We provide complete CTD (Common Technical Document) dossiers, COAs, GMP certificates, and stability data to facilitate rapid local registration.
Our nutritional and pharmaceutical lines emphasize sustainable sourcing. From plant extracts to bio-fermented raw materials, we align with the global "Green Pharma" initiative.
The future of pharmaceutical supply lies in Precision Manufacturing. Serum Pharma’s roadmap includes:
As the industry moves toward biologics, we are expanding our portfolio to include advanced biosimilar treatments. Our goal is to democratize access to life-saving therapies that were previously cost-prohibitive.
Pre-mix
Co-Crystallization
Bio-Fermentation
Focus on essential antibiotics (Amoxicillin, Ampicillin) and WHO-compliant manufacturing.
Customized nutritional solutions and plant extracts to meet regional health trends.
Deep expertise in local ANVISA and COFEPRIS regulatory requirements.
Stable supply of critical injectables like Ceftriaxone and Gentamicin with Russian/English labeling.
A: Every product undergoes a multi-stage validation process, including raw material analysis, in-process quality control (IPQC), and final batch testing in GMP-certified laboratories. We provide full COAs (Certificate of Analysis) for every shipment.
A: Yes. We provide comprehensive registration dossiers, including stability reports, manufacturing process descriptions, and bio-equivalence data to support your local Ministry of Health requirements.
A: Lead times typically range from 30 to 60 days, depending on the product type and manufacturing cycle. We maintain a strategic safety stock for high-demand molecules to facilitate faster delivery.
A: Through our "Development" division, we offer customization in Pre-Mix, Co-Crystallization, and Bio-Fermentation for both nutritional and pharmaceutical APIs.
